NCT03133260

Brief Summary

Major adverse cardiovascular events are the leading cause of perioperative morbimortality in non-cardiac surgery. Perioperative myocardial infarction is usually asymptomatic, with a mortality around 10-12%. Myocardial Injury in Noncardiac Surgery (MINS), is defined as a myocardial injury that provokes a troponin increase due to myocardial ischemia. MINS is a predictor of morbimortality at short term and at long term. The aim of the study is to improve the diagnosis of myocardial injury after non cardiac surgery in high-risk patients, improve its treatment in case of MINS and establish prevention strategies.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
800

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started May 2017

Longer than P75 for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

April 5, 2017

Completed
23 days until next milestone

First Posted

Study publicly available on registry

April 28, 2017

Completed
4 days until next milestone

Study Start

First participant enrolled

May 2, 2017

Completed
2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 30, 2019

Completed
2.5 years until next milestone

Study Completion

Last participant's last visit for all outcomes

October 15, 2021

Completed
Last Updated

March 22, 2022

Status Verified

March 1, 2022

Enrollment Period

2 years

First QC Date

April 5, 2017

Last Update Submit

March 19, 2022

Conditions

Outcome Measures

Primary Outcomes (1)

  • Prevalence of myocardial injury after non cardiac surgery (MINS).

    The aim of the study is to know the prevalence of myocardial injury after non cardiac surgery in high-risk surgical patients. The investigators will perform seriated troponin on the first 3 postoperative days, if troponin value are 30ng/L or more, the investigators will evaluate if troponin increase is due to cardiac or non-cardiac etiology (patients with TEP or sepsis will be excluded). Once the non-cardiac etiology is ruled out, it will be diagnosed of MINS

    From the day of surgery until the third postoperative day

Secondary Outcomes (6)

  • Percentage of MINS which corresponds to myocardial infarction

    From the day of surgery until the third postoperative day

  • Morbimortality in high-risk surgery patients until hospital discharge

    From the day of surgery until hospital discharge or until 30 days after surgery in case the patient still hospitalized

  • Compare the prognosis of patients with MINS versus patients who present a myocardial infarction versus who presented non of them.

    From the day of surgery until 1 year after surgery

  • Morbimortality in high-risk surgery patients 30 days after surgery

    From the day of surgery until 30 days after surgery

  • Morbimortality in high-risk surgery patients 6 months after surgery

    From the day of surgery until 6 months after surgery

  • +1 more secondary outcomes

Other Outcomes (1)

  • Analysis and validation of risk predictors for perioperative major adverse cardiovascular events.

    From the day of surgery until 1 year after surgery

Study Arms (1)

Non cardiac surgery

Determine perioperative troponin to diagnose perioperative MINS. In case of MINS acetylsalicylic acid and statins will be started if no contraindication. We will follow-up these patients for a year (including cardiologic evaluation after discharge)

Diagnostic Test: TroponinDrug: Acetylsalicylic acidDrug: Statin

Interventions

TroponinDIAGNOSTIC_TEST

Troponin will be measured before surgery and postoperative at days 1,2 and 3.

Non cardiac surgery

100mg acetylsalicylic acid will be started in case of MINS if no contraindication, it will be continued after hospital discharge. We will evaluate cardiovascular complications till 1 year after surgery

Non cardiac surgery
StatinDRUG

40mg atorvastatin will be started in case of MINS if no contraindication, it will be continued after hospital discharge. We will evaluate cardiovascular complications till 1 year after surgery

Non cardiac surgery

Eligibility Criteria

Age45 Years+
Sexall
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Patients of both genders over 45 years scheduled for non-urgent surgery with in-hospital stay of 24 hours minimum who require general and or regional anaesthesia (epidural or subarachnoidal) for high-risk surgery or middle risk-surgery with cardiovascular risk factors.

You may qualify if:

  • Patients of both genders over 45 years scheduled for non-urgent surgery with in-hospital stay of 24 hours minimum who require general and or regional anaesthesia (epidural or subarachnoidal) that have signed the inform consent who will be operated of:
  • \. High-risk surgery:
  • Open abdominal aortic aneurism repair
  • Major vascular surgery
  • Major amputations
  • Carotid endarterectomy
  • Duodeno-pancreatic surgery
  • Hepatic resection or resection of biliary duct
  • Esophagectomy
  • Suprarenal resection
  • Cystectomy
  • Pneumonectomy
  • \. Medium risk-surgery with cardiovascular risk factors (see below):
  • Intraperitoneal surgery (rectum, colon, small bowel, gastric surgery)
  • Peripherical angioplasty
  • +15 more criteria

You may not qualify if:

  • Patients without consent information

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Hospital Del Mar

Barcelona, 08003, Spain

Location

Related Publications (1)

  • Mases A, Beltran de Heredia S, Gallart L, Roman L, Bosch L, Nunez M, Rueda M, Recasens L, Sabate S. Prediction of Acute Myocardial Injury in Noncardiac Surgery in Patients at Risk for Major Adverse Cardiovascular and Cerebrovascular Events: A Multivariable Risk Model. Anesth Analg. 2023 Dec 1;137(6):1116-1126. doi: 10.1213/ANE.0000000000006469. Epub 2023 Apr 12.

MeSH Terms

Conditions

Wounds and Injuries

Interventions

AspirinHydroxymethylglutaryl-CoA Reductase Inhibitors

Intervention Hierarchy (Ancestors)

SalicylatesHydroxybenzoatesPhenolsBenzene DerivativesHydrocarbons, AromaticHydrocarbons, CyclicHydrocarbonsOrganic ChemicalsAnticholesteremic AgentsHypolipidemic AgentsAntimetabolitesMolecular Mechanisms of Pharmacological ActionPharmacologic ActionsChemical Actions and UsesEnzyme InhibitorsLipid Regulating AgentsTherapeutic Uses

Study Officials

  • Sandra Beltran, MD

    Anesthetist

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Anesthesiologyst deputy, MD.

Study Record Dates

First Submitted

April 5, 2017

First Posted

April 28, 2017

Study Start

May 2, 2017

Primary Completion

April 30, 2019

Study Completion

October 15, 2021

Last Updated

March 22, 2022

Record last verified: 2022-03

Data Sharing

IPD Sharing
Will not share

Locations